✦ LIBER ✦

Changes in alanine aminotransferase (ALT) and YMDD mutation profile associated with switching from lamivudine (LAM) to either adefovir dipivoxil (ADV) or combination LAM plus ADV in chronic hepatitis B (CHB) patients with LAM resistance

✍ Scribed by Peters, Marion; Martin, Paul; Sullivan, Mark; Kleber, Kristin; Ebrahimi, Ramin; Westland, Chirstopher; Delaney, William E.; Xiong, Shelly; Brosgart, Carol

Book ID: 122382890
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 247 KB
Volume: 124
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(03)83608-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

438 Continued safety and efficacy of add

438 Continued safety and efficacy of adding adefovir dipivoxil (ADV) to ongoing lamivudine (LAM) therapy in compensated chronic hepatitis B (CHB) patients with YMDD variant HBV: 2 year results

✍ R. Perrillo; B. Willems; N. Leung; C. Trepo; H.W.L. Hann; G. Lau; W.M. Lee; E. S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB